CME Group Inc. (NASDAQ:CME) has been assigned an average recommendation of “Hold” from the nine brokerages that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and five have given a buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $134.33.
Several equities analysts recently weighed in on CME shares. Royal Bank Of Canada reduced their target price on CME Group from $134.00 to $133.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 19th. Deutsche Bank AG reiterated a “buy” rating and set a $133.00 target price (down from $134.00) on shares of CME Group in a research report on Monday, May 15th. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. BidaskClub upgraded CME Group from a “sell” rating to a “hold” rating in a report on Friday, June 23rd. Finally, Jefferies Group LLC restated a “buy” rating and issued a $134.00 price objective (up from $128.00) on shares of CME Group in a report on Monday, July 17th.
Shares of CME Group (CME) opened at 123.26 on Friday. CME Group has a one year low of $98.95 and a one year high of $127.96. The company has a 50-day moving average of $123.41 and a 200 day moving average of $120.96. The stock has a market capitalization of $41.90 billion, a price-to-earnings ratio of 25.16 and a beta of 0.73.
CME Group (NASDAQ:CME) last released its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The firm had revenue of $925 million for the quarter, compared to the consensus estimate of $931.05 million. During the same period in the prior year, the business posted $1.14 earnings per share. The firm’s revenue for the quarter was up 2.1% compared to the same quarter last year. Equities research analysts forecast that CME Group will post $4.81 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be issued a dividend of $0.66 per share. The ex-dividend date is Thursday, September 7th. This represents a $2.64 annualized dividend and a dividend yield of 2.14%. CME Group’s payout ratio is currently 53.99%.
In related news, insider Sunil Cutinho sold 10,265 shares of the firm’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $117.85, for a total transaction of $1,209,730.25. Following the sale, the insider now directly owns 21,690 shares in the company, valued at approximately $2,556,166.50. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Derek Sammann sold 2,100 shares of the firm’s stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $117.86, for a total value of $247,506.00. Following the sale, the insider now owns 31,026 shares in the company, valued at $3,656,724.36. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 91,085 shares of company stock worth $11,242,896. Company insiders own 0.61% of the company’s stock.
A number of large investors have recently modified their holdings of CME. Huntington National Bank raised its stake in shares of CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock worth $100,000 after buying an additional 38 shares during the period. Fiduciary Trust Co. acquired a new stake in shares of CME Group during the second quarter worth $105,000. Coconut Grove Bank raised its stake in shares of CME Group by 95.7% in the first quarter. Coconut Grove Bank now owns 900 shares of the financial services provider’s stock worth $107,000 after buying an additional 440 shares during the period. Whittier Trust Co. raised its stake in shares of CME Group by 12.6% in the first quarter. Whittier Trust Co. now owns 1,030 shares of the financial services provider’s stock worth $122,000 after buying an additional 115 shares during the period. Finally, Parallel Advisors LLC raised its stake in shares of CME Group by 4.1% in the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock worth $128,000 after buying an additional 43 shares during the period. Hedge funds and other institutional investors own 83.29% of the company’s stock.
WARNING: This piece of content was reported by BNB Daily and is the property of of BNB Daily. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/19/brokerages-set-cme-group-inc-nasdaqcme-pt-at-129-29-updated-updated.html.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.